# Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies

> **NCT07670949** · NA · RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hematological Malignancies B

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-EV203 PET/CT

## Key facts

- **NCT ID:** NCT07670949
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670949, "Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*